Just a few days after the JPM Health Annual Meeting, the US media broke three news reports. After the world's top cancer research institute MD Anderson Cancer Center announced more than 900 layoffs, the diagnostic field rookie Counsyl and the personalized medical company Cancer Genetics On the 6th and 7th, the news of layoffs was released. Among them, Counsyl announced that it will cut about 5% of the company's employees.
After losing more than $100 million in the second half of last year, the MD Anderson Cancer Center, the nation's number one in the oncology department, finally announced more than 900 layoffs earlier this year, nearly 5% of the total number of employees in the agency. However, at the same time that the MD Anderson Cancer Center suffered losses and was forced to lay off employees, the chairman of the organization, Ronald A. DePinho received a bonus of up to $200,000 for his excellent work, and his annual salary was as high as $1.439 million, far higher than the average pay level of the Anderson Cancer Center.
Thanks to the original spectral genetics test and the SNP test that does not rely on sequencing, Counsyl has cooperated with more than 100 famous medical centers and doctors including the Yale Reproductive Medicine Center in recent years to promote and popularize technology based on the company. The in vitro fertilization/preimplantation genetic diagnosis (IVF/PGD) service addresses the fertility problem of couples with millions of genetic risks. In the middle of last year, Counsyl, who was dissatisfied with the traditional business, established an oncology business unit to try to spread the technology to the tumor diagnosis and treatment market. Counsyl announced a layoff of 5% in January due to an unknown reason for the mismanagement of new business. The 5% of the layoffs were mainly in the sales team of the company's oncology business unit.
Even in the event of an undesired layoff, Counsyl said the company will continue to develop and increase the company's investment in genetic cancer testing. Counsyl will launch an upgraded version of its carrier screening test in the second quarter of this year.
After the Nasdaq closed last Friday, Cancer Genetics randomly announced its layoff resolution. Since the beginning of 2016, Cancer Genetics has experienced a stock market crash and has been devastated. In January this year, it relied on layoffs to reduce expenses. At the same time, the layoffs of Cancer Genetics are accompanied by executive translocation.
Highlighter,Highlighter Makeup,Liquid Highlighter,Face Highlighter
Guangzhou Lingxue Cosmetics Co., Ltd , https://www.gzlxgj188.com